News
ACOG released updated clinical guidance on vaccination for COVID-19, respiratory syncytial virus and influenza during ...
The FDA granted regenerative medicine advanced therapy designation to VG801 for the treatment of Stargardt disease, according to a press release from VeonGen Therapeutics. VG801, a dual-AAV gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback